In April 2025, McDermott once again hosted its annual European Health & Life Sciences Symposium at the Shangri-La hotel in Paris. Attended by some 300 delegates from across the industry, participants including investors, innovators, finance providers and advisers enjoyed a wide-ranging agenda covering everything from transaction trends and financing innovation through to navigating policy shifts and identifying investment opportunities. In an era of intense innovation at the intersection of technology and biology, the healthcare industry is witnessing unprecedented advancements that present exciting openings for investors.
Read the full article: Investment Opportunities in European TechBio and Pharma Services //
Source: https://www.mwe.com/insights/investment-opportunities-in-techbio-and-pharma-services/